Locametz powder for solution, kit; Out of specification (unknown impurity)
Brand(s)
Last updated
Summary
Product
Locametz powder for solution, kit
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Audience
Healthcare
Industry
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Canada Inc. | Locametz powder for solution, kit | DIN 02537117 | Powder For Solution, Kit | Gallium (68 Ga) Gozetotide 25 mcg/vial | PG21CA2502 |
Issue
An unknown impurity is out of specification in the affected batch.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Health Care Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs - Radiopharmaceuticals
Companies
Novartis Pharmaceuticals Canada Inc.
100 700 Rue Saint-Hubert
Montreal QUÉBEC H2Y 0C1 CANADA
Published by
Health Canada
Audience
Healthcare
Industry
Recall class
Type III
Identification number
RA-81471
Get notified
Receive emails about new and updated recall and safety alerts.